Shariska Harrington, MD, MSCR

Gynecologic Oncology

Dr. Harrington.png

Shariska Harrington, MD, MSCR

Gynecologic Oncology



  • Bachelor of Arts in Biological Sciences: University of Chicago, Chicago IL

Medical School

  • David Geffen School of Medicine at UCLA/CDU, Los Angeles, CA


  • Obstetrics and Gynecology Residency: Henry Ford Hospital/Wayne State University, Detroit, MI 


  • Gynecologic Oncology Fellowship: University of Kansas Medical Center, Kansas City, KS 

Graduate School

  • Master of Science in Clinical Research: University of Kansas Medical Center, Kansas City, KS


Primary Location

St. Paul Cancer Center
310 Smith Ave N , Suite 100
Saint Paul, MN 55102
Phone: (651) 251-5500

Areas of Special Interest

  • Gynecologic Cancers
  • Health Equity
  • Robotic surgery
  • Clinical trials
  • Biomarker directed therapies
  • Evidence-based care


Philosophy of Care

All patients deserve equitable, evidence-based and compassionate healthcare. I strive to partner with patients to ensure that they understand every aspect of their care and are empowered to make the best decisions to serve their individual needs.


Academic Honors & Professional Achievements

  • Foundation for Women’s Cancer Young Investigator Award in Honor of Laurel Rice, MD 
  • Society for Reproductive Investigation’s Underrepresented Minority Program  
  • Residents as Teachers Scholar Program 
  • Transdisciplinary Research in Energetics and Cancer (TREC) Training Fellowship
  • TL1 Postdoctoral Clinical and Translational Research Training Program Award  
  • Ovarian Cancer Research Alliance- Ann & Sol Schreiber Mentored Investigator Award
  • 3rd place Poster Competition; University of Kansas Cancer Center Symposium  
  • Hippocrates Award for Resident Who Best Practices Art of Medicine 
  • CREOG Award for Outstanding Performance on CREOG In-Service Examination  
  • American Association for Cancer Research Scholar in Training Award 


Gupta VG, Hirst J, Petersen S, et al. Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer. Gynecol Oncol. 2021 Apr 15:S0090-8258(21)00325-5. doi: 10.1016/j.ygyno.2021.04.015. Epub ahead of print. PMID: 33867143.

Petersen S, Shahiri P, Jewell A, Spoozak L, Chapman J, Fitzgerald-Wolff S, Lai SM, Khabele D. Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas. Am J Surg. 2020 Dec 7;. doi: 10.1016/j.amjsurg.2020.12.009. PubMed PMID: 33309256

Ball, J, Thompson, J, Wulff-Burchfield, E, Ellerbeck, E, Kimminau, K, Brooks, J, Petersen S, Rotich, D, Kinney, A, Ellis, S.  “Precision community: a mixed methods study to identify determinants of adoption and implementation of targeted cancer therapy in community oncology.” Implement Sci Commun August 2020. 1:72

Doe, S, Petersen S, Buekers, T, Swain, M. Does a Multidisciplinary Approach to Invasive Breast Cancer Care Improve Time to Treatment and Patient Compliance? J Natl Med Assoc. 2020 Apr 11. doi: 10.1016/j.jnma.2020.03.010. PubMed PMID: 32291070. 


  • Society of Gynecologic Oncology 
  • American Association of Gynecologic Laparoscopists
  • American Congress of Obstetricians and Gynecologist

Surgery Locations

  • United Hospital


I was born and raised in Saint Croix, US Virgin Islands and spent the last several years traveling across the country to complete my medical training. My husband is a native of Detroit, MI, and we are excited to call Saint Paul home. We love traveling, experiencing live music, attending sporting events and trying out new restaurants. 

"All patients deserve equitable, evidence-based and compassionate healthcare."